Natasha Singer and Duff Wilson
The New York Times
September 17, 2009
The scientific integrity of medical research has been clouded in recent years by articles that were drafted by drug company-sponsored ghostwriters and then passed off as the work of independent academic authors.
Yet the leading medical journals have continued to rely largely on an honor system of disclosure to detect such potential bias, asking authors to voluntarily report any industry ties or contributors to their manuscripts.
But now, in light of recently released evidence that some drug makers have gone to great lengths to turn scientific articles into marketing vehicles for their products, some influential medical editors are cracking down on industry-financed ghostwriting. And they are getting help from some members of Congress.
Read entire article: http://www.nytimes.com/2009/09/18/business/18ghost.html?_r=1&hp
News Feed
Related Posts
Tags: antidepressants, conflicts of interest, ghost writing, ghostwriters, JAMA, Medical journals, NEJM, PLoS, Senator Charles Grassley
This entry was posted on Friday, September 18th, 2009 at 1:16 pm and is filed under News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.
Donate
What we will find behind the drug push scam pushed off on the world’s population is outright criminality, just look at the shady practices talked about in this very article– imagine what is behind this. Big pharma is a criminal organization and psychiatry is the vehicle which gets the drugs into the hands of the consumers. It needs to be stopped if human kind is to survive into the future. It will be THE fundamental flaw in man that is destroying this world.